These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35070848)
1. Lymphatic invasion is a significant indicator of poor patient outcome in canine bladder urothelial carcinoma. Govoni VM; Pigoli C; Sueiro FAR; Zuliani F; da Silva TO; Quitzan JG; Laufer-Amorim R; Grieco V; Fonseca-Alves CE Open Vet J; 2021; 11(4):535-543. PubMed ID: 35070848 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder. Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867 [TBL] [Abstract][Full Text] [Related]
3. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction. Mochizuki H; Shapiro SG; Breen M Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558 [TBL] [Abstract][Full Text] [Related]
4. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma. Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489 [TBL] [Abstract][Full Text] [Related]
5. Urothelial carcinoma with tonsillar metastasis in a dog. Mammone RM; Havis B; Royal A; Donnelly LL; Kim DY J Vet Diagn Invest; 2022 May; 34(3):564-567. PubMed ID: 35403515 [TBL] [Abstract][Full Text] [Related]
6. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494 [TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography. Macrì F; Di Pietro S; Mangano C; Pugliese M; Mazzullo G; Iannelli NM; Angileri V; Morabito S; De Majo M BMC Vet Res; 2018 Mar; 14(1):84. PubMed ID: 29530040 [TBL] [Abstract][Full Text] [Related]
8. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533 [TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic findings related to prognosis in canine transitional cell carcinoma. Hanazono K; Fukumoto S; Endo Y; Ueno H; Kadosawa T; Uchide T Vet Radiol Ultrasound; 2014; 55(1):79-84. PubMed ID: 23890180 [TBL] [Abstract][Full Text] [Related]
11. A Fibromyxoid Stromal Response is Associated with Muscle Invasion in Canine Urothelial Carcinoma. de Brot S; Grau-Roma L; Stirling-Stainsby C; Dettwiler M; Guscetti F; Meier D; Scase T; Robinson BD; Gardner D; Mongan NP J Comp Pathol; 2019 May; 169():35-46. PubMed ID: 31159949 [TBL] [Abstract][Full Text] [Related]
12. [Transitional cell carcinoma of the urinary bladder of a dog]. Odendaal JS; Bastianello SS J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501 [TBL] [Abstract][Full Text] [Related]
13. Urothelial Carcinomas of the Urinary Bladder With Plasmacytoid or Rhabdoid Features and Tendency of Epithelial-Mesenchymal Transition in 3 Dogs. Lin SJ; Kao CF; Wang FI; Jeng CR; Lee JJ; Wang LY; Chang HW; Chen YJ; Liu CH; Pang VF Vet Pathol; 2018 Sep; 55(5):673-677. PubMed ID: 29661121 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders. Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084 [TBL] [Abstract][Full Text] [Related]
15. Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma. Inoue A; Maeda S; Kinoshita R; Tsuboi M; Yonezawa T; Matsuki N Vet Immunol Immunopathol; 2017 Aug; 190():53-56. PubMed ID: 28778323 [TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder. Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650 [TBL] [Abstract][Full Text] [Related]
17. Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. Valli VE; Norris A; Jacobs RM; Laing E; Withrow S; Macy D; Tomlinson J; McCaw D; Ogilvie GK; Pidgeon G J Comp Pathol; 1995 Aug; 113(2):113-30. PubMed ID: 8543669 [TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72. Clemo FA; DeNicola DB; Carlton WW; Walker E; Morrison WB Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056 [TBL] [Abstract][Full Text] [Related]
19. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand. Lin TY; Zhang H; Wang S; Xie L; Li B; Rodriguez CO; de Vere White R; Pan CX Mol Cancer; 2011 Jan; 10(1):9. PubMed ID: 21272294 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Khan KN; Knapp DW; Denicola DB; Harris RK Am J Vet Res; 2000 May; 61(5):478-81. PubMed ID: 10803639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]